AlzChem Group AG stock analysis ACT0.DE

Alzchem Group AG is a specialty chemicals company whose primary business is producing highly functional chemical ingredients through an integrated value chain. Its core segment, Specialty Chemicals, comprises high-purity products such as Creamino® (a creatine feed additive), Creapure® (a branded creatine monohydrate for sports nutrition), Bioselect® (guanidine salts for pharmaceuticals and diagnostics), Dormex® (a plant growth regulator), nitroguanidine, and DYHARD® hardeners and accelerators for epoxy resin systems. These are produced in Alzchem's multi-purpose specialty facilities and represent the strategic focus for growth.

A second business segment is Basics & Intermediates, which provides raw and semi-finished materials that feed into the Specialty Chemicals segment or are sold independently. Key products include calcium carbide, calcium cyanamide, guanidine, guanamine, nitriles, and intermediates for agricultural, automotive, steel, and pharmaceutical industries. The company maintains a "Verbund Production" setup, integrating stages of production from basic raw materials to refined specialty chemicals along the calcium carbide/calcium cyanamide (NCN) chain.

Alzchem operates out of four production sites in the Bavarian Chemical Triangle in Germany plus a plant in Sundsvall, Sweden, with proprietary sales companies in the USA, China, and the UK. Its markets span agriculture, animal and human nutrition, pharmaceuticals, renewable energies, automotive and defense, among others. The company emphasizes research and development, technological specialization, high quality standards, supply reliability, and regulatory compliance as differentiators.